Trevi Therapeutics, Inc.
TRVI NASDAQ







Weekly Summary
Trevi Therapeutics, Inc. closed at 8.1500 (-4.57% WoW) . Data window ends Fri, 19 Sep 2025.
How to read this — Price slope is upward, indicating persistent buying over the window. Elevated weekly volatility increases whipsaw risk. Volume and price are moving in the same direction — a constructive confirmation. Distance to baseline is narrowing — reverting closer to its fair-value track. Constructive MA stack supports the up-drift; pullbacks may find support at the 8–13 week region. Price holds above key averages, indicating constructive participation.
Up-slope supports buying interest; pullbacks may be contained if activity stays firm.
Gauge maps the trend signal to a 0–100 scale.
How to read this — Gauge is elevated but momentum is rolling over; topping risk is rising. Notable breakdown from ≥0.80 weakens trend quality.
Stay alert: protect gains or seek confirmation before adding risk.

Relative strength is Positive
(> 0%, outperforming).
Latest MRS: 14.73% (week ending Fri, 19 Sep 2025).
Slope: Falling over 8w.
Notes:
- Holding above the zero line indicates relative bid.
- MRS slope falling over ~8 weeks.
Conclusion
Negative setup. ★★⯪☆☆ confidence. Trend: Uptrend at Risk · 11.19% over window · vol 5.10% · liquidity convergence · posture above · RS outperforming · leaning negative
- Price holds above 8–26 week averages
- Constructive moving-average stack
- Liquidity confirms the price trend
- Solid multi-week performance
- High level but momentum rolling over (topping risk)
- Momentum is weak/falling
- High return volatility raises whipsaw risk
- Recent breakdown from ≥0.80 weakens trend quality
Why: Price window 11.19% over w. Close is -1.21% below the prior-window high. Return volatility 5.10%. Volume trend rising. Liquidity convergence with price. Trend state uptrend at risk. MA stack constructive. Baseline deviation 1.43% (narrowing). Momentum bullish and falling.
Tip: Most metrics include a hover tooltip where they appear in the report.